<DOC>
	<DOCNO>NCT02049502</DOCNO>
	<brief_summary>The purpose study test whether Fecal Microbiota Transplant ( FMT ) safe effective treatment people Ulcerative Colitis ileal pouch anastomosis . Ulcerative colitis ( UC ) type inflammatory bowel disease ( IBD ) may cause person 's immune system respond unusual way bacteria normally find gut . Studies show gut bacteria people ulcerative colitis ( UC ) different gut bacteria people without ulcerative colitis ( UC ) . Often , people ulcerative colitis ( UC ) few type bacteria gut change way person 's immune system work . This study people proctocolectomy ileal pouch anastomosis ( IPAA ) treat ulcerative colitis ( UC ) . More 50 % people IPAA develop condition call pouchitis . Pouchitis short long-term inflammation ileal pouch create order store waste intestine . Patients pouchitis ask take part study . Currently , antibiotic , probiotic prebiotics use treat pouchitis . However , show probiotic helpful patient stop take . In addition , antibiotic may cause unfavorable side effect . Fecal microbiota transplantation ( FMT ) study another form treatment patient active pouchitis . Fecal microbiota transplantation ( FMT ) `` stool transplant '' involve receive single fecal enema someone volunteer donate stool . There two purpose research study : 1 . To see whether fecal microbiota transplantation ( FMT ) useful treatment patient ulcerative colitis ( UC ) associate pouchitis 2 . To study change within bacteria gut patient pouchitis ( study treatment ) use stool , blood urine sample</brief_summary>
	<brief_title>FMT Ulcerative Colitis-Associated Pouchitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Pouchitis</mesh_term>
	<criteria>male female age 18 65 year ulcerative colitisassociated pouchitis patient Emory Clinic and/or Emory University Hospital Age &lt; 18 year &gt; 65 year age Exposure immunosuppressive therapy ( define steroid , etanercept , antitumor necrosis factor ( TNF ) agent ) within 1 month prior enrollment Concomitant Clostridium difficile infection Suspected Crohn 's disease Documented active infection kind Patients anticoagulant therapy , platelet count less 50,000 , significant anemia hemoglobin le 7 condition place increase risk bleed Absolute neutrophil count ( ANC ) less 1000 history opportunistic infection Administration investigational drug within one month prior plan FMT Pregnant breastfeed woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>ulcerative colitis</keyword>
	<keyword>fecal microbiota transplantation</keyword>
</DOC>